Century Therapeutics Inc.
0.93
-0.01 (-0.56%)
At close: Jan 15, 2025, 12:33 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 2.23M 5.20M n/a n/a n/a
Cost of Revenue 13.04M 10.07M 4.58M 1.75M 249.00K
Gross Profit -10.81M -4.87M -4.58M -1.75M -249.00K
Operating Income -146.55M -133.83M -94.88M -53.90M -245.98M
Interest Income 12.68M 2.99M 898.00K 704.00K 1.21M
Pretax Income -134.79M -130.84M -95.78M -53.58M -244.77M
Net Income -136.67M -130.93M -95.82M -54.66M -245.98M
Selling & General & Admin 34.71M 31.86M 19.23M 9.49M 5.77M
Research & Development 92.71M 107.17M 75.65M 39.68M 14.27M
Other Expenses 21.36M 4.42M 377.00K 704.00K 1.21M
Operating Expenses 148.78M 139.03M 94.88M 49.18M 20.03M
Interest Expense 540.00K 1.10M 1.27M 381.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 148.78M 139.03M 94.88M 49.18M 20.03M
Income Tax 1.88M 91.00K 43.00K 1.08M 1.21M
Shares Outstanding (Basic) 59.31M 57.76M 55.01M 54.82M 54.82M
Shares Outstanding (Diluted) 59.31M 57.76M 55.01M 54.82M 54.82M
EPS (Basic) -2.3 -2.27 -1.74 -1 -4.49
EPS (Diluted) -2.3 -2.27 -1.74 -1 -4.49
EBITDA -121.21M -119.34M -89.92M -51.44M -19.78M
Depreciation & Amortization 13.04M 10.07M 4.58M 1.75M 249.00K